is mounjaro glp-1 use tripled among non-diabetics, reaching $5.8B in 2022 Mounjaro, Zepbound: Generic GLP-1 Drugs
Description
Diabetes Care 46 , 9981004 (2023)
& Dutta, S
[DOI] [PubMed] [Google Scholar] 14.Pohl S.L., Birnbaumer L., Rodbell M
:max_bytes(150000):strip_icc()/HDC-Mounjaro-vs-Ozempic-How-Do-These-Popular-Medications-Compare-528df44a2a4d4432b9bd9c1300354ec8.png)
Many state Medicaid programs classify these medications as non-essential for weight management alone, limiting access to individuals meeting narrow clinical definitions
Heres why: Context matters
Who Should Avoid GLP-1 Medications Even with a high BMI, not everyone is eligible for semaglutide or tirzepatide medications
